OBJECTIVE--To assess the frequency of early remodelling of coronary stenosis morphology after thrombolytic treatment in patients with acute myocardial infarction. DESIGN--Coronary angiograms were analysed by a computerised edge detection analysis system. Coronary stenosis severity was measured and morphology classified as smooth or complex. PATIENTS--Coronary arteriograms were obtained approximately 90 min and 24 h after thrombolytic treatment from 40 patients with acute myocardial infarction. MAIN RESULTS--Stenosis morphology was complex in 22 patients (65%) and smooth in 11 (32%) 90 min after thrombolysis. The morphology of 11 (50%) complex coronary stenoses and three (27%) smooth stenoses had changed at 24 h (P < 0.05). The transition from complex to smooth was associated with a reduction in stenosis severity from 65 (4)% to 51 (5)% (P < 0.05). The stenosis severity was 63 (4)% and 60 (5)% in those with persistently complex morphology, and 56 (7)% and 50 (5)% in those with persistently smooth morphology at 90 min and 24 h respectively (NS). CONCLUSIONS--Transition of morphology from complex to smooth within 24 h is common. This transition is associated with a reduction in stenosis severity of a degree greater than that found in persistently smooth stenoses over the same interval. 50% of stenoses are smooth at 24 h.

BACKGROUND Although abnormal vasoconstriction may be involved in the pathogenesis of the acute coronary syndromes, the vasoreactivity of the lesion responsible for unstable angina (culprit lesion) has not been directly investigated. It is also unknown if enhanced vasoreactivity is found downstream to this lesion or extends to uninvolved coronary arteries. METHODS AND RESULTS We studied seven unstable angina patients whose condition had sufficiently stabilized to allow ergometric bicycle exercise and a cold pressor test to be performed as provocative stimuli during coronary arteriography. We measured the luminal diameter of the culprit lesion, a normal-appearing distal segment, and the segment of an uninvolved coronary artery using quantitative coronary angiography. Seven stable angina patients served as controls. Antianginal medications were tapered and interrupted. The culprit lesion constricted significantly with exercise and the cold pressor test compared with a stable angina control lesion. The culprit lesion measured 1.41 +/- 0.07 mm at baseline and diminished to 1.09 +/- 0.07 mm with exercise (P = .001). It measured 1.26 +/- 0.07 mm before the cold pressor test and diminished to 1.09 +/- 0.03 mm with this test (P = .015). In contrast, the profile of the stable lesion in the stable angina control group differed significantly (P = .006). Its luminal diameter measured 1.42 +/- 0.17 mm at baseline and 1.48 +/- 0.21 mm with exercise (P = NS). It measured 1.57 +/- 0.18 mm before and 1.55 +/- 0.18 mm with the cold pressor test (P = NS). There were no significant changes to these stimuli in the uninvolved coronary artery segments in unstable angina and in the distal segments in both unstable and stable angina patients. CONCLUSIONS This study demonstrates increased vasoreactivity of the culprit lesion in unstable angina compared with a control lesion in stable angina. The lack of an effect either in the uninvolved coronary artery or downstream to the culprit lesion suggests that systemic neurohumoral or seeding mechanisms are not operative. This abnormal vasoreactivity might predispose to, or be a marker for, the recurrence of acute ischemia at this site.

BACKGROUND We have developed a new measure of myocardial viability, the water-perfusable tissue index (PTI), which is calculated from transmission, C15O, and H2(15)O positron emission tomography (PET) data sets. It is defined as the proportion of the total anatomical tissue within a given region of interest (ROI) that is capable of rapidly exchanging water and has units g (perfusable tissue)/g (total anatomical tissue). The aim of this study was to assess the prognostic value of PTI in predicting improvement in regional wall motion after successful thrombolysis for acute myocardial infarction (AMI) and to measure the myocardial blood flow to the perfusable tissue (MBFp, ml/min/g [perfusable tissue]). Furthermore, PTI was compared with 18FDG metabolic imaging in patients with old myocardial infarction (OMI). METHODS AND RESULTS PET scans were performed in healthy volunteers (group 1, n = 8), patients with OMI (group 2, n = 15), and in patients who were successfully thrombolysed after an AMI (group 3, n = 11). Systolic wall thickening was measured by two-dimensional echocardiography within 2-4 days of AMI and after 4 months to assess contractile recovery. In the healthy volunteers, MBFp was 0.95 +/- 0.13 ml/min/g (perfusable tissue). PTI in these regions was 1.08 +/- 0.07 g (perfusable tissue)/g (total anatomical tissue), which was consistent with all normal myocardium being perfusable by water. In the OMI group, the ratio of the relative 18FDG activity to the relative MBFp defect (metabolism-flow ratio) was calculated for each asynergic segment. Regions in which the metabolism-flow ratio was greater than or equal to 1.20 were considered reversibly injured, whereas those in which the ratio was less than 1.20 were deemed irreversibly injured. PTI in the former group of regions (n = 9) was 0.75 +/- 0.14 g (perfusable tissue)/g (total anatomical tissue) and was significantly higher than in irreversibly injured regions (n = 6) (0.53 +/- 0.12 g [perfusable tissue]/g [total anatomical tissue], p less than 0.01). Values of MBFp were similar in these segments. Seven of 12 segments in the AMI patients showed improved systolic wall thickening on follow-up. PTI in these recovery segments was 0.88 +/- 0.10 g (perfusable tissue)/g (total anatomical tissue) (p = NS versus control). PTI in the nonrecovery regions was 0.53 +/- 0.11 g (perfusable tissue)/g (total anatomical tissue), which was similar to the segments in group 2 in which 18FDG uptake was absent. MBFp was similar in both the recovery and nonrecovery segments in the subacute phase. CONCLUSIONS These data indicate that PTI may be a good prognostic indicator for the recovery of contractile function after successful thrombolysis and show that myocardial viability may be assessed by PET without metabolic imaging.

The efficacy of multiple intravenous bolus injections of tissue-type plasminogen activator (t-PA) in inducing rapid coronary recanalization in patients with acute myocardial infarction was previously demonstrated. In this Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST), the efficacy of 3 different doses of a single rapid intravenous bolus injection of t-PA (duteplase, Wellcome Foundation, London) in inducing coronary patency (Thrombolysis In Myocardial Infarction perfusion grade 2 or 3) in 64 patients with acute myocardial infarction presenting < 6 hours after onset of symptoms was investigated. At 60 minutes after administration of t-PA, the infarct-related coronary artery was patent in 9 of 17 patients (53%; 95% confidence interval [CI] 28 to 77%) after 0.3 MU/kg, in 14 of 23 (61%; 95% CI 39 to 80%) after 0.45 MU/kg and in 10 of 14 (71%; 95% CI 42 to 92%) after 0.6 MU/kg. At 90 minutes after t-PA, coronary patency was present in 9 of 17 cases (53%; 95% CI 28 to 77%) after 0.3 MU/kg, in 12 of 24 (50%; 95% CI 29 to 71%) after 0.45 MU/kg and in 10 of 13 (77%; 95% CI 46 to 95%) after 0.6 MU/kg. One patient in each dose group had a silent reoccluded infarct-related artery by 24 hours, and there were 2 clinical reinfarctions before discharge. No major bleeding events were observed. There were 5 hospital deaths, all unrelated to t-PA. A single intravenous bolus injection of 0.6 MU/kg of t-PA appears to be effective in inducing rapid coronary patency and to be safe in patients with acute myocardial infarction.

BACKGROUND The mechanism responsible for exercise-induced myocardial ischemia early after successful coronary angioplasty (PTCA) is poorly understood. METHODS AND RESULTS Twelve patients who underwent one-vessel PTCA were studied. Exercise testing was performed before and on day 7 after PTCA, which was repeated after 10 mg sublingual isosorbide dinitrate if the test was positive. Quantitative coronary arteriography was also performed on day 8 after PTCA in the basal state, after intracoronary infusion of 0.9% saline, 1, 5, 10, and 20 micrograms ergonovine, and after 300 micrograms nitroglycerin. All patients had a positive exercise test before PTCA but on day 7, six patients had a positive exercise test (group 1) and six patients (group 2) had a negative exercise test. In group 1, all positive exercise tests on day 7 became negative when repeated after isosorbide dinitrate. Intracoronary ergonovine was associated with a dose-dependent constriction of the PTCA segment, a segment distal to it, and a control segment, with no significant difference in the magnitude of the response between the two groups; maximum constriction for group 1 was 19 +/- 3%, 23 +/- 2%, and 16 +/- 3% (p less than 0.001 versus basal), and in group 2 was 20 +/- 4%, 18 +/- 4%, and 9 +/- 2% (p less than 0.01 versus basal). No angina, ischemic ST segment changes, occlusive, or subocclusive spasm occurred in any patient of either group. CONCLUSIONS We could find no evidence that exercise-induced myocardial ischemia early after PTCA is related to the presence of fixed angiographic restenosis or to dynamic constriction of any epicardial coronary segment. Therefore, inappropriate small coronary vessel constriction responsive to nitrates should be considered as a possible alternative explanation.

BACKGROUND:To study the impact of percutaneous transluminal coronary angioplasty (PTCA) on coronary vasomotion, we prospectively analyzed spontaneous changes in coronary diameter and the response to the cold pressor test and intracoronary nitroglycerin in 11 patients subjected to successful single-vessel PTCA.METHODS AND RESULTS:All antianginal medications were stopped 48 hours before each study. The minimum diameter of the PTCA segment and the diameter of a distal segment in the angioplastied vessel and of a segment in a control vessel not manipulated by the balloon catheter or guide wire were measured by computerized edge detection immediately before PTCA and 5 minutes after, 4 hours after, and 8 days after PTCA. At 4 hours, PTCA and distal segments were constricted by 38 +/- 9% and 16 +/- 5%, respectively, compared with the values at 5 minutes (p less than 0.01). Before angioplasty, the cold pressor test caused vasoconstriction of PTCA and distal segments by 23 +/- 6% (p less than 0.0001) and 15 +/- 4% (p less than 0.008), respectively, but no constrictor response was elicited at 5 minutes or 4 hours after angioplasty. Eight days after PTCA, the basal coronary diameters were similar to those observed 5 minutes after PTCA and the response to the cold pressor test was similar to that observed before PTCA. All segments dilated significantly with nitroglycerin at all times, and no vasoconstriction changes were found in the control segments.CONCLUSIONS:Four hours after PTCA, transient spontaneous vasoconstriction of the PTCA and distal segments occurs, which is so intense that the cold pressor test does not cause any further constriction. These abnormalities resolve within 8 days of PTCA.

Episodic platelet activation has been shown to occur in unstable angina, and aspirin should have an important therapeutic role in the management of these patients. The response to aspirin alone or to aspirin in combination with vasodilators such as heparin and beta-blockers has been assessed in 41 patients with unstable angina. Therapy was added sequentially in the event of recurrence of transient myocardial ischemia. Patients were randomly assigned to two groups. Group 1 (21 patients) received an intravenous infusion of isosorbide dinitrate and oral diltiazem, and group 2 (20 patients) received intravenous aspirin (60 mg the first day and 20 mg on successive days). This dose of aspirin reduced serum thromboxane B2 from 160 +/- 88 ng/ml (mean +/- SD) to undetectable values (less than 6 ng/ml, p less than 0.01). If episodes of ischemic ST segment shift continued, the therapy of group 1 was added to that of group 2 or vice versa; if further ST segment changes were documented, intravenous heparin and oral beta-blockers were added; if episodes of myocardial ischemia persisted, urgent coronary arteriography and myocardial revascularization were performed. Nine patients in group 1 and six in group 2 (p = 0.8) had no further episodes of myocardial ischemia on their initial therapy; 12 additional patients had no further episodes when taking combined therapy of aspirin and vasodilators. Thus, the administration of aspirin alone was not superior to coronary dilators; 30% of all patients continued to have episodes of myocardial ischemia or had a myocardial infarction develop when heparin and beta-blockers were added. Myocardial infarction occurred in one patient on vasodilator therapy alone, in two on combined therapy, and in two on full therapy. These results suggest that in some patients, the stimulus to coronary thrombosis and vasoconstriction occasionally becomes so strong that it cannot be inhibited by certain antagonist drugs. The unstable tendency to continuation of ischemia or evolution to myocardial infarction is not related to the severity of the persisting stenosis. Those patients not promptly responding to combined therapy immediately from admission should have early coronary angiography and aggressive treatment.

We compared the effects of isosorbide dinitrate (ISDN) administered by intracoronary and intravenous routes in 10 patients with severe coronary artery disease, stable effort angina, and very low exercise tolerance. Supine bicycle ergometer exercise was performed under four conditions: 1) control, 2) after intracoronary administration of 0.4 mg ISDN, 3) 1 hour later (control 2), and 4) after administration of intravenous 4 mg ISDN. At rest, intracoronary ISDN caused no significant hemodynamic effects, whereas intravenous infusion of ISDN resulted in a decline in left ventricular (LV) systolic pressure (-20 +/- 5 mm Hg), LV end-diastolic volume (-27 +/- 3%), and LV end-systolic volume (-30 +/- 4%). After intracoronary infusion of ISDN, ST segment depression and the increase in LV end-diastolic pressure and LV end-systolic volume induced by exercise were significantly less abnormal than during control (0.20 +/- 0.09 vs. 0.14 +/- 0.08 mV, 36 +/- 7 vs. 24 +/- 8 mm Hg, and 91 +/- 40% vs. 40 +/- 29%, respectively). When exercise was performed after intravenous infusion of ISDN, the above-mentioned parameters were significantly improved even further: ST segment depression to 0.05 +/- 0.07 mV, end-diastolic pressure to 14 +/- 7 mm Hg, and LV end-systolic volume to 5 +/- 11% (all p less than 0.01 compared with intracoronary ISDN). Thus, in patients with severe coronary artery disease, it is suggested that intracoronary nitrates increase coronary blood supply during effort-induced ischemia, based on significant improvements in the indirect measures of ST segment depression, LV end-diastolic pressure, and LV volume.(ABSTRACT TRUNCATED AT 250 WORDS)

Coronary arterial reperfusion is commonly associated, in anaesthetized animals, with severe arrhythmias, but the clinical relevance of this model remains uncertain. Continuous electrocardiographic ST-segment recording was performed immediately from admission in 38 patients who presented within six (mean 2.5) hours of the onset of acute myocardial infarction and had emergency coronary arteriography and thrombolysis with intracoronary streptokinase. All patients received high doses of isosorbide dinitrate but no prophylactic anti-arrhythmic drugs. In 19 patients, 36 occurrences of intermittent reperfusion were observed. Stable reperfusion was achieved in 32 patients. Only 14 episodes of arrhythmia (11 ventricular) were observed in 6 patients within five minutes of transient or stable reperfusion. No episodes of arrhythmia were documented within five minutes of the other 57 occurrences of reperfusion. In contrast, 215 episodes of arrhythmia (198 ventricular) not associated with reperfusion were recorded in 32 patients. Arrhythmias are commonly observed in patients during evolving acute myocardial infarction and thrombolysis but are an insensitive and rarely specific marker of reperfusion at the time when this occurs.

Prostacyclin is a powerful inhibitor of platelet aggregation and induces relaxation of vascular smooth muscle. We have studied the coronary effects of high local concentrations of prostacyclin in 17 patients during the early stages of acute myocardial infarction. We infused graded concentrations of intracoronary prostacyclin and compared the effects to those of intracoronary isosorbide dinitrate before and after an intracoronary infusion of streptokinase. Considerable dilation of the infarct-related stenosis may follow local infusions of prostacyclin in some patients. In general, however, dilation of the infarct-related stenosis or coronary recanalization did not result from infusion of prostacyclin.

To investigate the time course of restenosis, serial treadmill exercise testing was performed in the absence of medical therapy by 31 patients with single vessel coronary disease who underwent successful angioplasty. Exercise tests were performed before angioplasty and at 3 days and 1, 3 and 6 months after angioplasty; if the test was positive, it was repeated after administration of 10 mg of intravenous verapamil. At arteriography 6 months after coronary angioplasty, 17 patients (group 1) showed no restenosis but 14 patients (group 2) did. Before angioplasty all 31 patients had a positive exercise test with ST segment depression greater than or equal to 1 mm. At 3 days after angioplasty, three patients in group 1 had a positive exercise test compared with 11 patients in group 2 (p = 0.08). At 1, 3 and 6 months, 1 patient in group 1 had a positive exercise test compared with 14 patients in group 2 (p less than 0.01). The heart rate-blood pressure product (beats/min.mm Hg) calculated at 1 mm ST segment depression, or at peak exercise if the test was negative, was used as an index of the ischemic threshold. In group 1 (no restenosis) the ischemic threshold increased progressively from 14,840 +/- 1,075 (mean value +/- SEM) before angioplasty to 21,210 +/- 1,049 at 3 days and to 25,140 +/- 1,177 (p less than 0.001) at 6 months. In group 2 (restenosis) the ischemic threshold increased from 16,270 +/- 828 before angioplasty to 20,400 +/- 984 (p less than 0.0004) at 3 days but decreased to 16,090 +/- 1,298 (p less than 0.006) at 6 months.(ABSTRACT TRUNCATED AT 250 WORDS)

HomeCirculationVol. 81, No. 6Coronary artery spasm and vasoconstriction. The case for a distinction. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBCoronary artery spasm and vasoconstriction. The case for a distinction. A Maseri, G Davies, D Hackett and J C Kaski A MaseriA Maseri Cardiovascular Research Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England. , G DaviesG Davies Cardiovascular Research Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England. , D HackettD Hackett Cardiovascular Research Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England. and J C KaskiJ C Kaski Cardiovascular Research Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England. Originally published1 Jun 1990https://doi.org/10.1161/01.CIR.81.6.1983Circulation. 1990;81:1983–1991 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Suzuki S, Kaikita K, Yamamoto E, Jinnouchi H and Tsujita K (2020) Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease, Cardiovascular Intervention and Therapeutics, 10.1007/s12928-020-00720-z, 36:1, (39-51), Online publication date: 1-Jan-2021. Mercan Yücel U, Başbuğan Y, Uyar A, Kömüroğlu A and Keleş Ö (2020) Use of an antiarrhythmic drug against acute selenium toxicity, Journal of Trace Elements in Medicine and Biology, 10.1016/j.jtemb.2020.126471, 59, (126471), Online publication date: 1-May-2020. Waterbury T, Tarantini G, Vogel B, Mehran R, Gersh B and Gulati R (2019) Non-atherosclerotic causes of acute coronary syndromes, Nature Reviews Cardiology, 10.1038/s41569-019-0273-3, 17:4, (229-241), Online publication date: 1-Apr-2020. Nakamura T, Horikoshi T and Kugiyama K (2020) Relationship of a thinned medial layer to the attenuated contractile response in atherosclerotic coronary arteries, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00537.2019, 318:1, (H135-H142), Online publication date: 1-Jan-2020. Yasue H, Mizuno Y and Harada E (2019) Association of East Asian Variant Aldehyde Dehydrogenase 2 Genotype (ALDH2*2*) with Coronary Spasm and Acute Myocardial Infarction Aldehyde Dehydrogenases, 10.1007/978-981-13-6260-6_7, (121-134), . YASUE H, MIZUNO Y and HARADA E (2019) Coronary artery spasm — Clinical features, pathogenesis and treatment —, Proceedings of the Japan Academy, Series B, 10.2183/pjab.95.005, 95:2, (53-66), Online publication date: 8-Feb-2019. Wang H, Peng G, Dong Y and Liu D (2019) Intravascular ultrasound findings and stent implantation for a patient with coronary spastic angina at site of progressive atherosclerotic plaque and responded poorly to medical treatment: a case report, BMC Cardiovascular Disorders, 10.1186/s12872-019-01304-3, 19:1, Online publication date: 1-Dec-2019. Sánchez-Somonte P, Flores-Umanzor E and Sitges Carreño M (2017) Sudden cardiac death secondary to severe multivessel coronary spasm, Medicina Clínica (English Edition), 10.1016/j.medcle.2017.06.015, 149:2, (83), Online publication date: 1-Jul-2017. Maicas Bellido C, Alcalá López J and Hernández Simón P (2017) Síndrome cardíaco X. Angina vasoespástica. Isquemia silente, Medicine - Programa de Formación Médica Continuada Acreditado, 10.1016/j.med.2017.06.013, 12:36, (2174-2184), Online publication date: 1-Jun-2017. Sánchez-Somonte P, Flores-Umanzor E and Sitges Carreño M (2017) Muerte súbita secundaria a vasoespasmo coronario multivaso, Medicina Clínica, 10.1016/j.medcli.2017.03.028, 149:2, (83), Online publication date: 1-Jul-2017. Rha S and Ngow H (2017) Transradial Intracoronary Spasm Provocation Test Transradial Approach for Percutaneous Interventions, 10.1007/978-94-017-7350-8_26, (281-290), . Kaski J (2016) Stable Angina Pectoris: Definition, Clinical Presentation and Pathophysiologic Mechanisms Essentials in Stable Angina Pectoris, 10.1007/978-3-319-41180-4_2, (15-35), . Shimokawa H (2015) Coronary Artery Spasm: Clinical Aspect PanVascular Medicine, 10.1007/978-3-642-37078-6_259, (1827-1844), . Hovasse T, Jariwala P and Lefèvre T (2015) Spontaneous coronary artery spasm during coronary angiography: An uncommon manifestation of variant angina, Journal of Indian College of Cardiology, 10.1016/j.jicc.2014.04.006, 5:1, (103-106), Online publication date: 1-Mar-2015. Shimokawa H (2015) Coronary Artery Spasm: Basic Aspect PanVascular Medicine, 10.1007/978-3-642-37078-6_59, (1811-1825), . Shimokawa H (2014) 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities--from bench to bedside, European Heart Journal, 10.1093/eurheartj/ehu427, 35:45, (3180-3193), Online publication date: 1-Dec-2014. Radico F, Cicchitti V, Zimarino M and De Caterina R (2014) Angina Pectoris and Myocardial Ischemia in the Absence of Obstructive Coronary Artery Disease: Practical Considerations for Diagnostic Tests, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2014.01.157, 7:5, (453-463), Online publication date: 1-May-2014. Halna du Fretay X, Mohammed Saeed D and Benamer H (2014) Mort subite et angor spastique : quelle stratégie diagnostique et thérapeutique ?, Annales de Cardiologie et d'Angéiologie, 10.1016/j.ancard.2014.09.036, 63:6, (465-470), Online publication date: 1-Dec-2014. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira J, Gersh B, Gitt A, Hulot J, Marx N, Opie L, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Paul Taggart D, van der Wall E, Vrints C, Luis Zamorano J, Achenbach S, Baumgartner H, Bax J, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli M, Ponikowski P, Anton Sirnes P, Luis Tamargo J, Tendera M, Torbicki A, Wijns W, Windecker S, Knuuti J, Valgimigli M, Bueno H, Claeys M, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, González-Juanatey J, Hamilos M, Hasdai D, Husted S, James S, Kervinen K, Kolh P, Dalby Kristensen S, Lancellotti P, Pietro Maggioni A, Piepoli M, Pries A, Romeo F, Rydén L, Simoons M, Anton Sirnes P, Gabriel Steg P, Timmis A, Wijns W, Windecker S, Yildirir A and Luis Zamorano J (2014) Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Revista Española de Cardiología, 10.1016/j.recesp.2013.11.007, 67:2, (135.e1-135.e81), Online publication date: 1-Feb-2014. Shimokawa H (2014) Coronary Artery Spasm: Part I Clinical Aspect PanVascular Medicine, 10.1007/978-3-642-37393-0_259-1, (1-21), . Chang R, Lee M, Kan C, Hsu W and Hsiao P (2013) Oxaliplatin-induced acquired long QT syndrome with torsades de pointes and myocardial injury in a patient with dilated cardiomyopathy and rectal cancer, Journal of the Chinese Medical Association, 10.1016/j.jcma.2013.05.001, 76:8, (466-469), Online publication date: 1-Aug-2013. Lanzer P (2013) Interventional X-Ray Coronary Angiography Catheter-Based Cardiovascular Interventions, 10.1007/978-3-642-27676-7_16, (279-301), . Mischie A, Nazzaro M, Fiorilli R, De Felice F, Musto C, Confessore P, Parma A, Boschetti C and Violini R (2013) Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: The CREDENTIAL study, Catheterization and Cardiovascular Interventions, 10.1002/ccd.24844, 82:3, (E184-E191), Online publication date: 1-Sep-2013. Shimokawa H (2014) Coronary Artery Spasm, Part II Basic Aspects PanVascular Medicine, 10.1007/978-3-642-37393-0_59-1, (1-18), . (2013) 2013 ESC guidelines on the management of stable coronary artery disease, European Heart Journal, 10.1093/eurheartj/eht296, 34:38, (2949-3003), Online publication date: 7-Oct-2013. Maseri A (2012) Clinical evaluation of the patient with chest pain Coronary Atherosclerosis, 10.3109/9781841848549.006, (56-68), Online publication date: 1-Aug-2012. Marzilli M and Huqi A (2012) Coronary Vasospasm and Coronary Atherosclerosis, Journal of the American College of Cardiology, 10.1016/j.jacc.2011.11.014, 59:7, (663-664), Online publication date: 1-Feb-2012. Gan W, Davies H, Koehoorn M and Brauer M (2012) Association of Long-term Exposure to Community Noise and Traffic-related Air Pollution With Coronary Heart Disease Mortality, American Journal of Epidemiology, 10.1093/aje/kwr424, 175:9, (898-906), Online publication date: 1-May-2012., Online publication date: 1-May-2012. Thompson P (2011) History Coronary Care Manual, 10.1016/B978-0-7295-3927-2.10013-2, (98-103), . Kaski J, Arrebola-Moreno A and Dungu J (2011) Treatment strategies for chronic stable angina, Expert Opinion on Pharmacotherapy, 10.1517/14656566.2011.634799, 12:18, (2833-2844), Online publication date: 1-Dec-2011. Halna du Fretay X, Blanchard-Lemoine B, Schnebert B and Viossat J (2011) Angor spastique : quel regard en 2011 ?, Annales de Cardiologie et d'Angéiologie, 10.1016/j.ancard.2011.09.002, 60:6, (317-323), Online publication date: 1-Dec-2011. Summers M, Lerman A, Lennon R, Rihal C and Prasad A (2011) Myocardial ischaemia in patients with coronary endothelial dysfunction: insights from body surface ECG mapping and implications for invasive evaluation of chronic chest pain, European Heart Journal, 10.1093/eurheartj/ehr221, 32:22, (2758-2765), Online publication date: 2-Nov-2011. Sechtem U, Ong P, Athanasiadis A, Vöhringer M, Merher R and Yilmaz A (2010) Coronary Vasospasm: Is it a Myth?, American Journal Cardiovascular Drugs, 10.2165/1153642-S0-000000000-00000, 10, (19-26), Online publication date: 1-Dec-2010. Yagi H, Komukai K, Hashimoto K, Kawai M, Ogawa T, Anzawa R, Minai K, Nagoshi T, Ogawa K, Taniguchi I and Yoshimura M (2010) Difference in risk factors between acute coronary syndrome and stable angina pectoris in the Japanese: Smoking as a crucial risk factor of acute coronary syndrome, Journal of Cardiology, 10.1016/j.jjcc.2009.12.010, 55:3, (345-353), Online publication date: 1-May-2010. Dumont J, Meroufel D, Bauters C, Hansmannel F, Bensemain F, Cottel D, Hamon M, Lambert J, Ducimetière P, Amouyel P, Zureik M and Brousseau T (2009) Association of Ornithine Transcarbamylase Gene Polymorphisms With Hypertension and Coronary Artery Vasomotion, American Journal of Hypertension, 10.1038/ajh.2009.110, 22:9, (993-1000), Online publication date: 1-Sep-2009., Online publication date: 1-Sep-2009. Nickenig G and Sinning J (2009) Response to Drug-Eluting Stents, Journal of the American College of Cardiology, 10.1016/j.jacc.2009.07.048, 54:24, (2330-2332), Online publication date: 1-Dec-2009. Maseri A, Beltrame J and Shimokawa H (2009) Role of Coronary Vasoconstriction in Ischemic Heart Disease and Search for Novel Therapeutic Targets, Circulation Journal, 10.1253/circj.CJ-09-0033, 73:3, (394-403), . Yoo S and Kim J (2009) Recent Insights Into the Mechanisms of Vasospastic Angina, Korean Circulation Journal, 10.4070/kcj.2009.39.12.505, 39:12, (505), . Miwa Y, Masai H and Shimizu M (2009) Differential Effects of Calcium-Channel Blockers on Vascular Endothelial Function in Patients With Coronary Spastic Angina, Circulation Journal, 10.1253/circj.CJ-08-0188, 73:4, (713-717), . Kotake Y, Matsumoto M, Yorozu T and Takeda J (2009) Recurrent ST-segment elevation on ECG and ventricular tachycardia during neurosurgical anesthesia, Journal of Anesthesia, 10.1007/s00540-008-0691-6, 23:1, (115-118), Online publication date: 1-Feb-2009. Nuno D, Harrod J and Lamping K (2009) Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00407.2009, 297:4, (H1469-H1477), Online publication date: 1-Oct-2009. Ogawa T, Komukai K, Ogawa K, Kosuga T, Nagoshi T, Minai K, Sakamoto H, Hashimoto K, Yoshida S, Taniguchi I, Mochizuki S and Yoshimura M (2009) High Incidence of Repeat Anginal Attacks Despite Treatment With Calcium-Channel Blockers in Patients With Coronary Spastic Angina, Circulation Journal, 10.1253/circj.CJ-08-0501, 73:3, (512-515), . Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S and Saito Y (2008) Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel Blockers, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.12.049, 51:18, (1742-1748), Online publication date: 1-May-2008. Shin D, Seung K, Kim P, Chang K, Choi J, Jeon D, Kim M, Lee M and Chung W (2008) Long-Term Coronary Endothelial Function After Zotarolimus-Eluting Stent Implantation A 9 Month Comparison Between Zotarolimus-Eluting and Sirolimus-Eluting Stents, International Heart Journal, 10.1536/ihj.49.639, 49:6, (639-652), . Yasue H, Nakagawa H, Itoh T, Harada E and Mizuno Y (2008) Coronary artery spasm—Clinical features, diagnosis, pathogenesis, and treatment, Journal of Cardiology, 10.1016/j.jjcc.2008.01.001, 51:1, (2-17), Online publication date: 1-Feb-2008. Nishijima T, Nakayama M, Yoshimura M, Abe K, Yamamuro M, Suzuki S, Shono M, Sugiyama S, Saito Y, Miyamoto Y, Nakao K, Yasue H and Ogawa H (2007) The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm, Pharmacogenetics and Genomics, 10.1097/01.fpc.0000239978.61841.1a, 17:8, (581-587), Online publication date: 1-Aug-2007. Shin D, Kim P, Seung K, Kim D, Kim M, Chang K, Lim S, Jeon D, Chung W, Baek S and Lee M (2007) Drug-Eluting Stent Implantation Could Be Associated With Long-Term Coronary Endothelial Dysfunction, International Heart Journal, 10.1536/ihj.48.553, 48:5, (553-567), . Suzuki S, Yoshimura M, Nakayama M, Abe K, Yamamuro M, Nagayoshi Y, Kojima S, Kaikita K, Sugiyama S, Yasue H and Ogawa H (2007) A novel genetic marker for coronary spasm in women from a genome-wide single nucleotide polymorphism analysis, Pharmacogenetics and Genomics, 10.1097/FPC.0b013e328136bd35, 17:11, (919-930), Online publication date: 1-Nov-2007. Muto M, Saitoh S, Osugi T, Matsumoto K, Aikawa K, Onogi F, Ishibashi T and Maruyama Y (2006) Differing effects of metoprolol and propranolol on large vessel and microvessel responsiveness in a porcine model of coronary spasm, Coronary Artery Disease, 10.1097/01.mca.0000236283.64059.70, 17:7, (629-635), Online publication date: 1-Nov-2006. Yamada K, Tsuji H, Tokunaga S, Kurimoto K, Maeba H, Matsuhisa S, Inami N and Iwasaka T (2006) Effect of beta-blockers on the mortality of Japanese patients with myocardial infarction, International Journal of Cardiology, 10.1016/j.ijcard.2005.05.015, 108:3, (309-313), Online publication date: 1-Apr-2006. Wada M, Hara H and Nakamura M (2006) A change in the pattern of vasospasm after stenting in a patient with vasospastic angina, Heart and Vessels, 10.1007/s00380-006-0920-6, 21:6, (388-391), Online publication date: 27-Nov-2006. Rotondo S, Dell'Elba G, Manarini S, Cerletti C and Evangelista V (2006) The lipoxygenase–cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbit, European Journal of Pharmacology, 10.1016/j.ejphar.2006.06.052, 546:1-3, (95-101), Online publication date: 1-Sep-2006. Adlam D, Azeem T, Ali T and Gershlick A (2005) Is there a role for provocation testing to diagnose coronary artery spasm?, International Journal of Cardiology, 10.1016/j.ijcard.2004.07.016, 102:1, (1-7), Online publication date: 1-Jun-2005. Ayyildiz O, Karabulut A, Isikdogan A, Cakir O and Dursun M (2005) 5-Fluorouracil-induced vasospastic angina, Annals of Saudi Medicine, 10.5144/0256-4947.2005.263b, 25:3, (263-265), Online publication date: 1-May-2005. Konidala S and Gutterman D (2004) Coronary vasospasm and the regulation of coronary blood flow, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2003.10.001, 46:4, (349-373), Online publication date: 1-Jan-2004. Angiolillo D, Biasucci L, Liuzzo G and Crea F (2004) La inflamación en los síndromes coronarios agudos: mecanismos e implicaciones clínicas, Revista Española de Cardiología, 10.1016/S0300-8932(04)77128-6, 57:5, (433-446), Online publication date: 1-Jan-2004. Angiolillo D, Biasucci L, Liuzzo G and Crea F (2004) Inflammation in Acute Coronary Syndromes: Mechanisms and Clinical Implications, Revista Española de Cardiología (English Edition), 10.1016/S1885-5857(06)60174-6, 57:5, (433-446), Online publication date: 1-May-2004. Nakayama M, Yoshimura M, Sakamoto T, Shimasaki Y, Nakamura S, Ito T, Abe K, Yamamuro M, Miyamoto Y, Saito Y, Nakao K, Yasue H and Ogawa H (2003) Synergistic interaction of T???786???C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm, Pharmacogenetics, 10.1097/00008571-200311000-00004, 13:11, (683-688), Online publication date: 1-Nov-2003. Evangelista V, Dell'elba G, Celardo A, Manarini S and Cerletti C (2003) TxA2-mediated myocardial ischemia as a consequence of an acute lung inflammatory reaction in the rabbit, Journal of Thrombosis and Haemostasis, 10.1046/j.1538-7836.2003.00067.x, 1:2, (314-319), Online publication date: 1-Feb-2003. Mohri M, Shimokawa H and Takeshita A (2002) Coronary Artery Spasm: Clinical Aspects Pan Vascular Medicine, 10.1007/978-3-642-56225-9_57, (921-930), . Dimitrow P (2002) Coronary Endothelial Dysfunction in Patients With Hypertrophic Cardiomyopathy, Chest, 10.1378/chest.121.4.1374, 121:4, (1374), Online publication date: 1-Apr-2002. Kodama-Takahashi K, Ohshima K, Yamamoto K, Iwata T, Hamada M, Hiwada K and Murakami E (2002) Occurrence of Transient U-Wave Inversion During Vasospastic Anginal Attack Is Not Related to the Direction of Concurrent ST-Segment Shift, Chest, 10.1378/chest.122.2.535, 122:2, (535-541), Online publication date: 1-Aug-2002. Shimokawa H, Mohri M and Takeshita A (2002) Coronary Artery Spasm: Basic Aspects Pan Vascular Medicine, 10.1007/978-3-642-56225-9_56, (912-920), . Maseri A and Lanza G (2001) Fluorouracil-induced coronary artery spasm, The American Journal of Medicine, 10.1016/S0002-9343(01)00930-5, 111:4, (326-327), Online publication date: 1-Sep-2001. Hamabe A, Takase B, Uehata A, Kurita A, Ohsuzu F and Tamai S (2001) Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of vitamin C, The American Journal of Cardiology, 10.1016/S0002-9149(01)01485-0, 87:10, (1154-1159), Online publication date: 1-May-2001. Moriyama Y, Tsunoda R, Harada M, Miyao Y, Yoshimura M, Kugiyama K, Ogawa H and Yasue H (2001) Nitric Oxide-Mediated Vasodilatation is Decreased in Forearm Resistance Vessels in Patients With Coronary Spastic Angina, Japanese Circulation Journal, 10.1253/jcj.65.81, 65:2, (81-86), . Kodama-Takahashi K, Shigematsu Y, Hamada M, Hiwada K, Kazatani Y, Matsuzaki K and Murakami E (2001) Coronary Vasospasm in Hypertrophic Cardiomyopathy, Chest, 10.1016/S0012-3692(15)52104-1, 119:4, (1290-1291), Online publication date: 1-Apr-2001. Nedeljkovic M, Ostojic M, Beleslin B, Nedeljkovic I, Marinkovic J, Babic R, Stankovic G, Stojkovic S, Saponjski J, Djordjevic-Dikic A, Stepanovic J, Petrasinovic Z, Vukcevic V, Nedeljkovic S and Kanjuh V (2001) Efficiency of ergonovine echocardiography in detecting angiographically assessed coronary vasospasm, The American Journal of Cardiology, 10.1016/S0002-9149(01)02058-6, 88:10, (1183-1187), Online publication date: 1-Nov-2001. Okumura K, Osanai T, Kosugi T, Hanada H, Ishizaka H, Fukushi T, Kamada T, Miura T, Hatayama T, Nakano T, Fujino Y and Homma Y (2000) Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response, Journal of the American College of Cardiology, 10.1016/S0735-1097(00)00966-9, 36:6, (1847-1852), Online publication date: 1-Nov-2000. Hort W and Schwartzkopff B (2000) Anatomie und Pathologie der Koronararterien Pathologie des Endokard, der Kranzarterien und des Myokard, 10.1007/978-3-642-56944-9_3, (209-553), . Shimokawa H (2000) Cellular and Molecular Mechanisms of Coronary Artery Spasm, Japanese Circulation Journal, 10.1253/jcj.64.1, 64:1, (1-12), . Lanza G and Maseri A (2000) Coronary artery spasm, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-000-0031-0, 2:1, (83-90), Online publication date: 1-Feb-2000. Teragawa H, Kato M, Yamagata T, Matsuura H and Kajiyama G (2000) The Preventive Effect of Magnesium on Coronary Spasm in Patients With Vasospastic Angina, Chest, 10.1378/chest.118.6.1690, 118:6, (1690-1695), Online publication date: 1-Dec-2000. Takaoka K, Yoshimura M, Ogawa H, Kugiyama K, Nakayama M, Shimasaki Y, Mizuno Y, Sakamoto T and Yasue H (2000) Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking, International Journal of Cardiology, 10.1016/S0167-5273(99)00172-2, 72:2, (121-126), Online publication date: 1-Jan-2000. Karila-Cohen D, Delpy E, Dubois-Randé J, Puybasset L, Hittinger L, Giudicelli J and Berdeaux A (2009) Influence of the endothelium, nitric oxide and serotonergic receptors on coronary vasomotor responses evoked by ergonovine in conscious dogs, British Journal of Pharmacology, 10.1038/sj.bjp.0702635, 127:4, (1039-1047), Online publication date: 1-Jun-1999. Dorigo P, Maragno I, Santostasi G and Fraccarollo D (2009) Endothelium is required in the vascular spasm induced by tetraethylammonium and endothelin-1 in guinea-pig aorta, British Journal of Pharmacology, 10.1038/sj.bjp.0702557, 127:2, (505-513), Online publication date: 1-May-1999. Podolec P, Jasek S, Droste C, Kardos A, Tracz W and Roskammt H (1999) Continuously Recorded Physical Activity Level During Myocardial Ischemia Detected by Ambulatory Electrocardiography, Annals of Noninvasive Electrocardiology, 10.1111/j.1542-474X.1999.tb00052.x, 4:2, (137-143), Online publication date: 1-Apr-1999. Maseri A and Lanza G (1999) Vasospastic Angina Contemporary Concepts in Cardiology, 10.1007/978-1-4615-5007-5_6, (114-124), . Beltrame J, Sasayama S and Maseri A (1999) Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and caucasian patients, Journal of the American College of Cardiology, 10.1016/S0735-1097(99)00073-X, 33:6, (1442-1452), Online publication date: 1-May-1999. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y and Nakao K (1998) Association of the Missense Glu298Asp Variant of the Endothelial Nitric Oxide Synthase Gene With Myocardial Infarction, Journal of the American College of Cardiology, 10.1016/S0735-1097(98)00167-3, 31:7, (1506-1510), Online publication date: 1-Jun-1998. Ishida T, Hirata K, Sakoda T, Kanazawa K, Kawashima S, Akita H and Yokoyama M (1998) 5-HT1Dβ Receptor Mediates the Supersensitivity of Isolated Coronary Artery to Serotonin in Variant Angina, Chest, 10.1378/chest.113.1.243, 113:1, (243-244), Online publication date: 1-Jan-1998. Yoshimura M, Oshima T, Hiraga H, Nakano Y, Matsuura H, Yamagata T, Shiode N, Kato M, Kambe M and Kajiyama G (1998) Increased cytosolic free Mg 2+ and Ca 2+ in platelets of patients with vasospastic angina , American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.1998.274.2.R548, 274:2, (R548-R554), Online publication date: 1-Feb-1998. Yamada T, Okamoto M, Sueda T, Hashimoto M, Matsuura H and Kajiyama G (1998) Ergonovine-Induced Alterations in Coronary Flow Velocity Preceding Onset of Occlusive Spasm in Patients Without Significant Coronary Artery Stenoses, The American Journal of Cardiology, 10.1016/S0002-9149(97)01030-8, 81:6, (688-693), Online publication date: 1-Mar-1998. Tousoulis D, Daves G and Kaski J (1998) A comparative study of eccentric and concentric coronary stenosis vasomotion in patients with prinzmetal's variant angina and patients with stable angina pectoris, Clinical Cardiology, 10.1002/clc.4960210907, 21:9, (643-648), Online publication date: 1-Sep-1998. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H and Yasue H (1998) Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina, Journal of the American College of Cardiology, 10.1016/S0735-1097(98)00447-1, 32:6, (1672-1679), Online publication date: 1-Nov-1998. Auch-Schwelk W (1998) Koronarer Spasmus — Ein klinisch relevantes Problem?Coronary vasospasm — A clinically relevant problem?, Herz, 10.1007/BF03044541, 23:2, (106-115), Online publication date: 1-Mar-1998. Saitoh T, Kishida H, Hanashi A, Tsukada Y, Fukuma Y, Sano J, Fukuma N, Kusama Y and Hayakawa H (1998) Coronary Hyperreactivity to Adrenergic Stimulation and Increased Nocturnal Vagal Tone Trigger Coronary Vasospasm, Japanese Circulation Journal, 10.1253/jcj.62.721, 62:10, (721-726), . Strauer B, Schwartzkopff B and Kelm M (1998) Assessing the coronary circulation in hypertension, Journal of Hypertension, 10.1097/00004872-199816090-00001, 16:9, (1221-1233), Online publication date: 1-Sep-1998. Minshall R, Miyagawa K, Chadwick C, Novy M and Hermsmeyer K (1998) In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones , The FASEB Journal, 10.1096/fasebj.12.13.1419, 12:13, (1419-1429), Online publication date: 1-Oct-1998. Hermsmeyer K, Miyagawa K, Kelley S, Rösch J, Hall A, Axthelm M and Greenberg B (1997) Reactivity-Based Coronary Vasospasm Independent of Atherosclerosis in Rhesus Monkeys, Journal of the American College of Cardiology, 10.1016/S0735-1097(96)00524-4, 29:3, (671-680), Online publication date: 1-Mar-1997. Sakata K, Miura F, Sugino H, Saegusa T, Shirotani M, Yoshida H, Hoshino T and Kurata C (1997) Assessment of regional sympathetic nerve activity in vasospastic angina: Analysis of iodine 123–labeled metaiodobenzylguanidine scintigraphy, American Heart Journal, 10.1016/S0002-8703(97)70199-6, 133:4, (484-489), Online publication date: 1-Apr-1997. Bøtker H, Frøbert O, Møller N, Christiansen E, Schmitz O and Bagger J (1997) Insulin resistance in cardiac syndrome X and variant angina: Influence of physical capacity and circulating lipids, American Heart Journal, 10.1016/S0002-8703(97)70129-7, 134:2, (229-237), Online publication date: 1-Aug-1997. Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden E, Escudero X, Lablanche J, Amouyel P and Bertrand M (1997) The Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Coronary Artery Vasoconstriction, Journal of the American College of Cardiology, 10.1016/S0735-1097(96)00535-9, 29:3, (486-490), Online publication date: 1-Mar-1997. Motoyama T, Kawano H, Kugiyama K, Okumura K, Ohgushi M, Yoshimura M, Hirashima O and Yasue H (1997) Flow-mediated, endothelium-dependent dilatation of the brachial arteries is impaired in patients with coronary spastic angina, American Heart Journal, 10.1016/S0002-8703(97)70218-7, 133:3, (263-267), Online publication date: 1-Mar-1997. Miyagawa K, Rösch J, Stanczyk F and Hermsmeyer K (1997) Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm, Nature Medicine, 10.1038/nm0397-324, 3:3, (324-327), Online publication date: 1-Mar-1997. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kawamoto T, Kaji S, Morioka S and Yoshikawa J (1997) Comparison of Coronary Flow Reserve Between Focal and Diffuse Vasoconstriction Induced by Ergonovine in Patients With Vasospastic Angina, The American Journal of Cardiology, 10.1016/S0002-9149(97)00499-2, 80:6, (705-710), Online publication date: 1-Sep-1997. Cox I and Crook R (1996) The pathology and pathophysiology of coronary artery disease Angiology in Practice, 10.1007/978-94-011-5406-2_11, (121-138), . DOMINITZ I, BORUCHOW I and HUTCHINS G (1996) Focal Myocardial Ischemic Necroses Associated With Unstable Angina Pectoris, Journal of the American College of Cardiology, 10.1016/S0735-1097(96)00250-1, 28:4, (910-914), Online publication date: 1-Oct-1996. Hori R, Suzuki T and Hayano J (1996) Association between type a behavior pattern and coronary artery spasm in japanese patients, International Journal of Behavioral Medicine, 10.1207/s15327558ijbm0303_3, 3:3, (221-232), Online publication date: 1-Sep-1996. Palleschi L, Gianni W, De Vincentis G, Banci M, Sottosanti G, Ierardi M, Scopinaro F and Marigliano V (2016) Dipyridamole Technetium-99M Sestamibi Imaging in the Diagnosis of Syndrome X, Angiology, 10.1177/000331979604700407, 47:4, (369-373), Online publication date: 1-Apr-1996. Murakami Y, Ishinaga Y, Sano K, Murakami R, Kinoshita Y, Kitamura J, Kobayashi K, Okada S, Shimada T, Morioka S and Matsubara K (1996) Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina, Clinical Cardiology, 10.1002/clc.4960190606, 19:6, (473-476), Online publication date: 1-Jun-1996. Wen Lieng Lee , Chen J, Chi Woon Kong , Jiann Jong Wang , Ting C, Wan Leong Chan , Wang S and Chang M (2016) Changes in Cardiac Autonomic Activities in Patients with Syndrome X, Angiology, 10.1177/000331979604701001, 47:10, (929-939), Online publication date: 1-Oct-1996. Kugiyama K, Yasue H, Ohgushi M, Motoyama T, Kawano H, Inobe Y, Hirashima O and Sugiyama S (1996) Deficiency in nitric